NI-0801
Based on 1 Customer Validation
NI-0801 (EB 06) is a CXCL10 inhibitor with a Kd of 140 pM. NI-0801 blocks the CXCL10-CXCR3 interaction. NI-0801 selectively binds human CXCL10 but not CXCL9 or CXCL11, and inhibits CXCL10-induced calcium flux, chemotaxis, and lymphocyte transendothelial migration.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 99.19%
- Molecular Weight:146.08 kDa
-
Speicherung:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
[3]|
CXCL10 140 pM (Kd) |
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Anwendung
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized Human IP-10/CXCL10 Protein can bind NI-0801. The EC50 for this effect is 2.326 ng/mL.
Chemical Information
-
Appearance Liquid
-
Molecular Weight 146.08 kDa
-
Color Colorless to light yellow
-
Synonyms
EB 06
-
Versand
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
-
Data Sheet (259 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)